Sign in/sign up

ACN Newswire

LATEST ANNOUNCEMENT

    - MSD collaboration to investigate QBiotics' lead molecule tigilanol tiglate in combination with KEYTRUDA(R) (pembrolizumab)- Tigilanol tiglate is a novel, small molecule being developed as an intratumoural treatment for solid tumours - Melanoma th